Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome ODYSSEY OUTCOMES Trial

ODYSSEY OUTCOMES Committees and Investigators, 3 Sep 2019, In: Journal of the American College of Cardiology. 74, 9, p. 1167-1176 10 p.

Research output: Contribution to journal › Article › peer-review

Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery

ODYSSEY OUTCOMES Committees and Investigators, 3 Sep 2019, In: Journal of the American College of Cardiology. 74, 9, p. 1177-1186 10 p.

Research output: Contribution to journal › Article › peer-review

Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial

ODYSSEY OUTCOMES Committees and Investigators, 1 Sep 2019, In: European Heart Journal. 40, 33, p. 2801-2809 9 p.

Research output: Contribution to journal › Article › peer-review

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

ODYSSEY OUTCOMES Committees and Investigators, Aug 2019, In: The Lancet Diabetes and Endocrinology. 7, 8, p. 618-628 11 p.

Research output: Contribution to journal › Article › peer-review

Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial

ODYSSEY OUTCOMES Committees and Investigators, 9 Jul 2019, In: Circulation. 140, 2, p. 103-112 10 p.

Research output: Contribution to journal › Article › peer-review

Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial

ODYSSEY OUTCOMES Committees and Investigators, 5 Feb 2019, In: Journal of the American College of Cardiology. 73, 4, p. 387-396 10 p.

Research output: Contribution to journal › Article › peer-review

Correction of hypertriglyceridemia in order to reduce the residual risk in atherosclerosis-related diseases. Expert Council Opinion

Arutyunov, G. P., Boytsov, S. A., Voevoda, M. I., Drapkina, O. M., Kukharchuk, V. V., Martynov, A. I., Shestakova, M. V., Gurevich, V. S., Sergienko, I. V., Alieva, A. S., Akhmedzhanov, N. M., Bubnova, M. G., Galyavich, A. S., Gordeev, I. G., Yezhov, M. V., Karpov, Y. A., Konstantinov, V. O., Nedogoda, S. V., Nifontov, E. M., Orlova, Y. A. & 6 others, Panov, A. V., Saiganov, S. A., Skibitsky, V. V., Tarlovskaya, E. I., Urazgildeeva, S. A. & Halimov, Y. S., 1 Jan 2019, In: Russian Journal of Cardiology. 24, 9, p. 44-51 8 p.

Research output: Contribution to journal › Article › peer-review

Register of patients with familial hypercholesterolemia and patients of very high cardiovascular risk with lipid-lowering therapy underperformance (RENESSANS)

Yezhov, M. V., Bliznyuk, S. A., Tmoyan, N. A., Rozhkova, T. A., Duplyakov, D. V., Salchenko, V. A., Kachkovsky, M. A., Shaposhnik, I. I., Genkel, V. V., Gurevich, V. S., Urazgildeeva, S. A., Tregubov, A. V., Muzalevskaya, M. V., Bazhan, S. S., Timoshchenko, O. V., Urvantseva, I. A., Kozhokar, K. G., Sokolov, A. A., Tishko, V. V., Boyeva, O. I. & 34 others, Bolotova, E. V., Namitokov, A. M., Kushnaryova, Y. B., Kuznetsova, T. Y., Korneva, V. A., Bogdanov, D. Y., Chichina, E. E., Solovyov, V. M., Ershova, A. I., Meshkov, A. N., Makogonenko, V. I., Galyavich, A. S., Sadykova, D. I., Pomogaybo, B. V., Barbarash, O. L., Kashtalap, V. V., Shutemova, E. A., Isaeva, I. G., Khokhlov, R. A., Oleynikov, V. E., Avdeeva, I. V., Malakhov, V. V., Chubykina, U. V., Konstantinov, V. O., Aliyeva, A. S., Ovsyannikova, V. V., Furmenko, G. I., Chernykh, T. M., Abashina, O. E., Dzhanibekova, A. R., Slastnikova, E. S., Galimova, L. F., Duplyakova, P. D. & Voyevoda, M. I., 1 Jan 2019, In: Russian Journal of Cardiology. 24, 5, p. 7-13 7 p.

Research output: Contribution to journal › Article › peer-review

The influence of rs4986790 polymorphism of tlr4 gene on clinical manifestation of atherosclerosis in patients with familial hypercholesterolemia

Muzalevskaia, M., Urazgildeeva, S., Pobozheva, I., Razgildina, N., Miroshnikova, V., Konovalova, T., Trtegubov, A. & Gurevich, V., 2019, In: Atherosclerosis. 287, p. e246

Research output: Contribution to journal › Meeting Abstract › peer-review

Возможности клинического применения препарата эзетимиба Отрио (АО «АКРИХИН», Россия) у пациентов высокого и очень высокого сердечно-сосудистого риска, не достигших целевых значений показателей липидного обмена. Заключение Совета экспертов

Kobalava, J. D., Gurevich, V. S., Galyavich, A. S., Kaminnyi, A. I., Kashtalap, V. V., Mareev, V. Y., Susekov, A. V. & Shaposhnik, I. I., 2019, In: Kardiologiya. 59, 5, p. 47-57 11 p.

Research output: Contribution to journal › Article › peer-review